Paper · 41850312
Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy.
Zennami K and 7 others. Cancer Sci, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy. Papers, record 41850312. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41850312
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Genomic Profiling in Localized Prostate Cancer: Associations With Biochemical Recurrence and Response to Salvage Radiotherapy.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Humans | |
| Male | |
| Salvage Therapy | |
| Aged | |
| Middle Aged | |
| BRCA2 Protein | |
| Gene Expression Profiling | |
| Prostatectomy | |
| Histone-Lysine N-Methyltransferase | |
| Disease-Free Survival | |
| Genomics | |
| PTEN Phosphohydrolase | |
| Prostate-Specific Antigen |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23,569,316 | Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. | J Clin Oncol | 2013 | https://conductscience.org/library/papers/23569316 | PubMed |
| 2 | 40,393,864 | The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis. | Eur Urol | 2025 | https://conductscience.org/library/papers/40393864 | PubMed |
| 3 | 30,341,162 | Maftools: efficient and comprehensive analysis of somatic variants in cancer. | Genome Res | 2018 | https://conductscience.org/library/papers/30341162 | PubMed |
| 4 | 38,918,844 | Identification of metastasis-related genes for predicting prostate cancer diagnosis, metastasis and immunotherapy drug candidates using machine learning approaches. | Biol Direct | 2024 | https://conductscience.org/library/papers/38918844 | PubMed |
| 5 | 23,622,243 | The histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSα. | Cell | 2013 | https://conductscience.org/library/papers/23622243 | PubMed |
| 6 | 36,912,538 | Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. | N Engl J Med | 2023 | https://conductscience.org/library/papers/36912538 | PubMed |
| 7 | 32,619,406 | SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways. | Cancer Cell | 2020 | https://conductscience.org/library/papers/32619406 | PubMed |
| 8 | 27,363,387 | Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. | Eur Urol | 2016 | https://conductscience.org/library/papers/27363387 | PubMed |
| 9 | 28,825,054 | Prospective Genomic Profiling of Prostate Cancer Across Disease States Reveals Germline and Somatic Alterations That May Affect Clinical Decision Making. | JCO Precis Oncol | 2017 | https://conductscience.org/library/papers/28825054 | PubMed |
| 10 | 37,173,901 | Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37173901 | PubMed |
1 to 10 of 28
See all 28 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
None in this release.
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| ERBB3 | 2,065 | PubTator's text mining | https://conductscience.org/library/genes/2065 | NCBI Gene |
| MYC | 4,609 | PubTator's text mining | https://conductscience.org/library/genes/4609 | NCBI Gene |
| PLAG1 | 5,324 | PubTator's text mining | https://conductscience.org/library/genes/5324 | NCBI Gene |
| POLD1 | 5,424 | PubTator's text mining | https://conductscience.org/library/genes/5424 | NCBI Gene |
| PTEN | 5,728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
| SETD2 | 29,072 | PubTator's text mining | https://conductscience.org/library/genes/29072 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41850312
GET https://conductscience.org/api/papers/v1/41850312/references?page=2